1. Home
  2. Live Updates
  3. Reast carcinoma

Live Breaking News & Updates on Reast carcinoma

Stay informed with the latest breaking news from Reast carcinoma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Reast carcinoma and stay connected to the pulse of your community

Gilead Sciences Pauses Enrollment for Cancer Treatment in Solid Tumor Trials

Gilead Sciences said on Thursday enrollments to test its cancer drug, magrolimab, on solid tumors had been paused globally, a week after the U.S. regulator put some studies...

Bengaluru , Karnataka , India , Innovent-biologics , Pratik-jain , Gilead-sciences , Reuters , Drug-administration , Forty-seven-inc , Anild-silva , Breast-cancer , Alignant-breast-neoplasm

Cancer Surgery Tied to Increased Venous Thromboembolism Risk

A new study suggested that the risk for venous thromboembolism remains significant for 1 year after surgery for most cancers.

United-states , Sweden , Stockholm , American , Swedish , American-society-of-clinical-oncology , European-association-of-urology , Karolinska-institute , American-society , Clinical-oncology , European-association

Screening and Treatment Reduce Breast Cancer Mortality

Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019.

United-states , Surveillance-modeling-network , National-comprehensive-cancer-network-outcomes , Cancer-intervention , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma , Breast-cancer-screening , Advanced-breast-cancer , Etastatic-breast-carcinoma , Etastatic-breast-cancer

US FDA Puts Hold on Gilead's Blood Cancer Therapy Trials

Gilead Sciences said on Wednesday the U.S. Food and Drug Administration had put a hold on trials testing the company's blood cancer drug following increased risk of patient...

Bengaluru , Karnataka , India , Eli-lilly , Innovent-biologics , Khushi-mandowara , Sriraj-kalluvila , Reuters , Drug-administration , Forty-seven-inc , Gilead-sciences , Breast-cancer

Robotic Mastectomy Is Feasible, But Is it Safe?

One expert asks whether there is sufficient information about the oncologic safety of robotic mastectomy.

New-york , United-states , Memorial-sloan-kettering-cancer-center , Monica-morrow , University-of-texas , Drug-administration , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma , Robotic-surgery , Obotics , Partial-mastectomy

Does Eliminating Alcohol Intake Lower Cancer Risk?

When it comes to the link, a new report from WHO revealed limited or inadequate evidence to suggest consuming less alcohol or stopping altogether reduced the risk for most cancers.

United-states , American , Georgef-koob , Human-services , International-agency-for-research-on-cancer , World-health-organization , Department-of-health , National-institute-on-alcohol-abuse , Us-department-of-agriculture , American-cancer-society , Dry-january

Cardiorespiratory Fitness May Cut Prostate Cancer Risk

A new study adds to evidence that exercise reduces all-cause mortality risk across many cancer types, including prostate.

United-kingdom , Stockholm , Sweden , British , Swedish , Katea-bolam , Health-sciences , Swedish-school-of-sport , British-journal , Sports-medicine , Swedish-school

Olaparib combo improves PFS in metastatic prostate cancer

Frontline olaparib plus abiraterone/prednisone combo improves survival in patients with metastatic castration-resistant prostate cancer.

United-kingdom , Canada , Vancouver , British-columbia , Chicago , Illinois , United-states , British , Maha-hussain , Kimn-chi , Roberth-lurie-comprehensive-cancer-center , Astrazeneca

WHO: Global Cancer Burden Rising Amid Striking Inequities

Globally, an estimated 20 million people developed cancer in 2022 -- a figure expected to increase 77% to 35 million by 2050, with poorer countries bearing the brunt, according to new data.

Spain , United-states , American , Eduard-teixidor , Isabelle-soerjomataram , Bente-mikkelsen , Freddie-bray , American-cancer-society , International-agency-for-research-on-cancer , Catalan-institute-of-oncology , Science-media-centre , Human-development-index

Surveillance for 21 Possible Effects of Endocrine Disruptors

The French national public health agency holds that the scope of its surveillance must be expanded beyond reproductive health.

France , French , National-strategy , Publique-france , Malignant-testicular-neoplasm , Esticular-cancer , Ancer-of-the-testes , Disease-surveillance , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma